Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer

Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer

Pooja Advani,1 Lauren Cornell,2 Saranya Chumsri,1 Alvaro Moreno-Aspitia1 1Division of Hematology and Oncology, 2Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA Abstract: Human epidermal growth factor receptor 2 (HER2) is a tyrosine kinase transmembrane receptor that is overexpre...

Full description

Bibliographic Details
Main Authors: Advani P, Cornell L, Chumsri S, Moreno-Aspitia A
Format: Article
Language:English
Published: Dove Medical Press 2015-09-01
Series:Breast Cancer: Targets and Therapy
Online Access:https://www.dovepress.com/dual-her2-blockade-in-the-neoadjuvant-and-adjuvant-treatment-of-her2-p-peer-reviewed-article-BCTT

Internet

https://www.dovepress.com/dual-her2-blockade-in-the-neoadjuvant-and-adjuvant-treatment-of-her2-p-peer-reviewed-article-BCTT

Similar Items